Showing results (831-840 of 3,103) with videos related to
Sort By:
Pageof 311
Drug Safety|October 5, 2021
Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001-2015Annette Kjær Ersbøll, Kaushik Sengupta, Eero Pukkala, et al.Drug Safety|June 13, 2019
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy VolunteersJessica Ackert, Khadeeja Mohamed, Jason S Slakter, et al.Drug Safety|October 23, 2021
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label StudyFumihiko Sakai, Norihiro Suzuki, Xiaoping Ning, et al.Drug Safety|February 18, 2022
Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety ReportsCamille Azam, Louis Buscail, Adrian Culetto, et al.Drug Safety|February 3, 2022
Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug AdministrationDavid Croteau, Ellen Pinnow, Eileen Wu, et al.Drug Safety|March 5, 2022
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting DataWajd Alkabbani, Ryan Pelletier, Michael A Beazely, et al.Drug Safety|May 8, 2019
Pharmacovigilance as Scientific Discovery: An Argument for Trans-DisciplinarityElena Rocca, Samantha Copeland, I Ralph EdwardsDrug Safety|March 19, 1999
The Internet and drug safety: what are the implications for pharmacovigilance?B Cobert, J SilveyDrug Safety|March 19, 1999
The medical dictionary for regulatory activities (MedDRA)E G Brown, L Wood, S WoodPageof 311